Ameriprise
CLCD

Ameriprise’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Ameriprise’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-29,814
Closed -$1.08M – 3798
2016
Q4 		$1.08M Sell
29,814
-27,197
-48% -$962K ﹤0.01% 2933
2016
Q3 		$2.17M Buy
+57,011
New +$843K ﹤0.01% 2530

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Ameriprise's CLCD Position: Q1 2017 in Review

Ameriprise sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 29,814 shares — an estimated $1.08M sold.

Ameriprise first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $2.17M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Ameriprise reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Ameriprise sold 29,814 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.08M.
  • Ameriprise first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Ameriprise's CoLucid Pharmaceuticals, Inc. position peaked at $2.17M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Ameriprise's 13F filing for Q1 2017, filed 5 May 2017.